Fortress Biotech, Inc. revenue decreases to $12.43 million in quarter ended Mar 31, 2023 from previous quarter
Key fundamental financials- loss of $55.14 million
- Revenue of $12.43 million
Current Reporting | Revenue | Net Income | Profit/Loss |
---|---|---|---|
Mar 2023 | $12.43 million | $55.14 million | loss |
Sep 2022 | $16,528 | $53,060 | loss |
Jun 2022 | $18.89 million | $53.93 million | loss |
Candorium Free Members
Join Candorium to access the full article and more